Here, David Leitham, senior vice president and general manager at AspenTech, explains how implementing PAT pushes the industry towards Pharma 4.0.
Until recently, the push towards Pharma 4.0 had primarily been undertaken on a project-by-project basis. The focus was on addressing digitalisation by investigating point solutions across the product lifecycle, removing or replacing paper processes, using digital technologies to automate analytics and generally piloting/developing competencies to start a digital transformation.
It has sometimes been a slow process. Pharmaceutical manufacturers have historically found it difficult to embrace change. All pharmaceutical businesses by necessity have well-established, often complex, proven validation processes in place. If a technology has been through this cycle and is working in the manufacturing environment, businesses are often reluctant to take on further ‘evaluation pain’ in a bid to achieve more rapid time to value.
Over the past year, we have seen the process of change accelerate and the industry move ever closer to realising the dream of Pharma 4.0 and escape the loop of everlasting pilot activity. COVID-19 has fast-tracked the drive to speed up broader Pharma 4.0 initiatives, particularly with regards to using innovative techniques and partnerships to bring vaccines to market, supply chain and manufacture, contract organisation integration and other lifecycle elements.
This report addresses the key factors shaping pharmaceutical formulation, including regulation, QC and analysis.
Access the full report now to discover the techniques, tools and innovations that are transforming pharmaceutical formulation, and learn how to position your organisation for long-term success.
What you’ll discover:
Key trends shaping the pharmaceutical formulation sector
Innovations leading progress in pharmaceutical formulation and how senior professionals can harness their benefits
Considerations and best practices when utilising QbD during formulation of oral solid dosage forms
the industry is beginning to shift its focus away from a conservatively academic outlook and on to applied innovation”
With existing manual processes less easy to execute thanks to social distancing, the industry is beginning to shift its focus away from a conservatively academic outlook and on to applied innovation. In this context, many manufacturers are intensely concentrated on reducing supply chain disruption, increasing capacity of batch production and minimising batch losses. Reducing lifecycle maintenance costs and CAPEX remain high on the agenda too. Notwithstanding compliance and safety, manufacturing equipment availability is therefore a top priority.
To address this challenge, we have seen the evolution of predictive and prescriptive maintenance capabilities. The latest asset performance management (APM) solutions leverage such capabilities to enable pharmaceuticals companies to protect their supply chain, increase asset utilisation and avoid unplanned downtime by predicting when equipment anomalies will occur, understanding why they do and prescribing how to avoid potential failures.
Running in parallel, we are seeing solutions driving further efficiencies for pharmaceuticals manufacturers, enabling them to:
Increase collaboration, from lab to pilot plant to API manufacturing
Simulate end-to-end batch processes with first-principle models, accelerating regulatory approval and scale-up to full production
Identify factors impacting product quality and process efficiency using multivariate analytics
The above capabilities offer ideal starting points for pharma organisations looking to quickly gain value and reduce costs through digitalisation. However, in order for organisations to consolidate gains and continuously optimise processes over time, they need to start moving from achieving pockets of efficiency towards more co-ordinated and overarching closed loop solutions, where accuracy is improved over time.
The rise of PAT
Capabilities like predictive analytics for APM and multivariate analytics for monitoring process behaviours that impact batch quality, in particular, will ultimately lead to closed loop Process Analytical Technology (PAT) solutions. For more than 15 years, PAT has been a well-reputed and promising approach to faster, better and more integrated manufacturing processes in pharmaceuticals, ensuring quality though the process versus testing for quality after completion.
The promises and visions associated with PAT have a lot in common with trends like Industry 4.0 and Internet of Things (IoT). While these new trends have placed themselves firmly on the management agenda, PAT has not so far achieved the same attention at the management level. The time is definitely now to change this, as PAT is very much an enabler for digital transformation, and ultimately for Pharma 4.0, in the production and development department of pharma manufacturers.
PAT leverages real-time data and measurements, along with advanced analytics to better understand and to adjust operational processes in order to improve the end quality of the product itself. Moving forwards, it will increasingly become fundamental to the whole pharmaceuticals manufacturing process.
Indeed, we are already seeing this starting to happen today. PAT tools are continuously getting better, simpler and more robust, which, in turn, is helping to lower the threshold for implementation. As little as five years ago, a PAT project often ended up simply as a development project, with no immediate direct commercial benefit. Today, as long as the right application is chosen, a PAT project can be all about implementation – reducing project risk and saving pharmaceuticals manufacturers from a number of avoidable pitfalls and delays.
Whether a manufacturer’s PAT project turns into an implementation or just a development project depends on the planning phase. Choosing the tools and technologies that scale-up and can integrate into existing infrastructure is a must. Next, organisations should also consider the future direction of PAT; to be future-proof, the business will need to choose a PAT system which supports a range of data source types, for instance. Moreover, businesses implementing PAT, should never underestimate either the need for early results to ensure that the benefit of their project is recognised.
Final thoughts
By measuring the results they achieve, manufacturers will attain quantifiable benefits they can build on and scale up over time. It is about providing a robust control environment and secure documentation and compliance and, ultimately, unlocking the value from using PAT in a future-proof commercial environment. Once manufacturers have got that right, they will have gone a long way on the path not just to PAT but also Pharma 4.0. They will have embedded digitalisation into their manufacturing processes; and will be well-placed to monitor and control processes to achieve optimum quality of the final manufactured product.
About the author
David Leitham is Senior Vice President and General Manager at AspenTech. He has 25 years’ experience in the pharmaceutical industry and is responsible for expanding AspenTech’s footprint in the pharmaceuticals market, shaping the product and solution strategy and leading go-to-market efforts. David has demonstrated a track record of success integrating and transforming software businesses and products and growing them at double digits, while leading a software portfolio that drove over one billion dollars in connected sales. Prior to joining AspenTech, David was Vice President and General Manager at Thermo Fisher Scientific, where he was responsible for a team that consistently delivered double-digit growth in software revenue.
This website uses cookies to enable, optimise and analyse site operations, as well as to provide personalised content and allow you to connect to social media. By clicking "I agree" you consent to the use of cookies for non-essential functions and the related processing of personal data. You can adjust your cookie and associated data processing preferences at any time via our "Cookie Settings". Please view our Cookie Policy to learn more about the use of cookies on our website.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorised as ”Necessary” are stored on your browser as they are as essential for the working of basic functionalities of the website. For our other types of cookies “Advertising & Targeting”, “Analytics” and “Performance”, these help us analyse and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these different types of cookies. But opting out of some of these cookies may have an effect on your browsing experience. You can adjust the available sliders to ‘Enabled’ or ‘Disabled’, then click ‘Save and Accept’. View our Cookie Policy page.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Cookie
Description
cookielawinfo-checkbox-advertising-targeting
The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertising & Targeting".
cookielawinfo-checkbox-analytics
This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Analytics".
cookielawinfo-checkbox-necessary
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance
This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Performance".
PHPSESSID
This cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
viewed_cookie_policy
The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
zmember_logged
This session cookie is served by our membership/subscription system and controls whether you are able to see content which is only available to logged in users.
Performance cookies are includes cookies that deliver enhanced functionalities of the website, such as caching. These cookies do not store any personal information.
Cookie
Description
cf_ob_info
This cookie is set by Cloudflare content delivery network and, in conjunction with the cookie 'cf_use_ob', is used to determine whether it should continue serving “Always Online” until the cookie expires.
cf_use_ob
This cookie is set by Cloudflare content delivery network and is used to determine whether it should continue serving “Always Online” until the cookie expires.
free_subscription_only
This session cookie is served by our membership/subscription system and controls which types of content you are able to access.
ls_smartpush
This cookie is set by Litespeed Server and allows the server to store settings to help improve performance of the site.
one_signal_sdk_db
This cookie is set by OneSignal push notifications and is used for storing user preferences in connection with their notification permission status.
YSC
This cookie is set by Youtube and is used to track the views of embedded videos.
Analytics cookies collect information about your use of the content, and in combination with previously collected information, are used to measure, understand, and report on your usage of this website.
Cookie
Description
bcookie
This cookie is set by LinkedIn. The purpose of the cookie is to enable LinkedIn functionalities on the page.
GPS
This cookie is set by YouTube and registers a unique ID for tracking users based on their geographical location
lang
This cookie is set by LinkedIn and is used to store the language preferences of a user to serve up content in that stored language the next time user visit the website.
lidc
This cookie is set by LinkedIn and used for routing.
lissc
This cookie is set by LinkedIn share Buttons and ad tags.
vuid
We embed videos from our official Vimeo channel. When you press play, Vimeo will drop third party cookies to enable the video to play and to see how long a viewer has watched the video. This cookie does not track individuals.
wow.anonymousId
This cookie is set by Spotler and tracks an anonymous visitor ID.
wow.schedule
This cookie is set by Spotler and enables it to track the Load Balance Session Queue.
wow.session
This cookie is set by Spotler to track the Internet Information Services (IIS) session state.
wow.utmvalues
This cookie is set by Spotler and stores the UTM values for the session. UTM values are specific text strings that are appended to URLs that allow Communigator to track the URLs and the UTM values when they get clicked on.
_ga
This cookie is set by Google Analytics and is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. It stores information anonymously and assign a randomly generated number to identify unique visitors.
_gat
This cookies is set by Google Universal Analytics to throttle the request rate to limit the collection of data on high traffic sites.
_gid
This cookie is set by Google Analytics and is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visited in an anonymous form.
Advertising and targeting cookies help us provide our visitors with relevant ads and marketing campaigns.
Cookie
Description
advanced_ads_browser_width
This cookie is set by Advanced Ads and measures the browser width.
advanced_ads_page_impressions
This cookie is set by Advanced Ads and measures the number of previous page impressions.
advanced_ads_pro_server_info
This cookie is set by Advanced Ads and sets geo-location, user role and user capabilities. It is used by cache busting in Advanced Ads Pro when the appropriate visitor conditions are used.
advanced_ads_pro_visitor_referrer
This cookie is set by Advanced Ads and sets the referrer URL.
bscookie
This cookie is a browser ID cookie set by LinkedIn share Buttons and ad tags.
IDE
This cookie is set by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
li_sugr
This cookie is set by LinkedIn and is used for tracking.
UserMatchHistory
This cookie is set by Linkedin and is used to track visitors on multiple websites, in order to present relevant advertisement based on the visitor's preferences.
VISITOR_INFO1_LIVE
This cookie is set by YouTube. Used to track the information of the embedded YouTube videos on a website.